A MULTI-CENTER PHASE II STUDY OF INTRA-ARTERIAL CHEMOTHERAPY OF A FINE-POWDER FORMULATION OF CISPLATIN IN PATIENTS WITH ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA

被引:0
|
作者
Nakachi, K. [1 ]
Okusaka, T. [2 ]
Iguchi, H. [3 ]
Shimamura, T. [4 ]
Ioka, T. [5 ]
Hosokawa, A. [6 ]
Ikeda, M. [1 ]
Morizane, C. [2 ]
Asagi, A. [3 ]
Junji, F. [7 ]
机构
[1] Natl Canc Ctr Hosp E, Div Hepatobiliary Pancreat Oncol, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Div Hepatobiliary Pancreat Oncol, Tokyo, Japan
[3] Natl Hosp Org, Shikoku Canc Ctr, Dept Gastroenterol, Matsuyama, Ehime, Japan
[4] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan
[5] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pancreat & Hepatobiliary Oncol, Osaka, Japan
[6] Toyama Univ, Fac Med, Dept Gastroenterol & Hematol, Toyama 930, Japan
[7] Kyorin Univ, Sch Med, Div Med Oncol, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:121 / 121
页数:1
相关论文
共 50 条
  • [31] PHASE I STUDY OF SORAFENIB IN COMBINATION WITH LOW-DOSE CISPLATIN AND FLUOROURACIL INTRA-ARTERIAL INFUSION CHEMOTHERAPY
    Ueshima, Kazuomi
    Kudo, Masatoshi
    Tanaka, Masatoshi
    Kumada, Takashi
    Chung, Hobyung
    Hagiwara, Satoru
    Inoue, Tatsuo
    Yada, Norihisa
    Minami, Yasunori
    Sakurai, Toshiharu
    HEPATOLOGY, 2011, 54 : 1402A - 1403A
  • [32] Hepatic intra-arterial chemotherapy with gemcitabine:: An opening phase II study in patients with liver metastases of breast cancer.
    Eichler, K
    Zangos, S
    Mack, MG
    Balzer, JO
    Söllner, O
    Herzog, C
    Engelmann, K
    Vogl, TJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 61S - 61S
  • [33] Intra-arterial hepatic bio-chemotherapy for the treatment of melanoma patients with liver metastasis: A phase II clinical study
    Chi, Z.
    Cui, C.
    Yuan, X.
    Si, L.
    Sheng, X.
    Shen, L.
    Guo, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study
    Jun Li
    Mohamed Moustafa
    Michael Linecker
    Georg Lurje
    Ivan Capobianco
    Janine Baumgart
    Francesca Ratti
    Falk Rauchfuss
    Deniz Balci
    Eduardo Fernandes
    Roberto Montalti
    Ricardo Robles-Campos
    Bergthor Bjornsson
    Stefan A. Topp
    Jiri Fronek
    Chao Liu
    Roger Wahba
    Christiane Bruns
    Stefan M. Brunner
    Hans J. Schlitt
    Asmus Heumann
    Björn-Ole Stüben
    Jakob R. Izbicki
    Jan Bednarsch
    Enrico Gringeri
    Elisa Fasolo
    Jens Rolinger
    Jakub Kristek
    Roberto Hernandez-Alejandro
    Andreas Schnitzbauer
    Natascha Nuessler
    Michael R. Schön
    Sergey Voskanyan
    Athanasios S. Petrou
    Oszkar Hahn
    Yuji Soejima
    Emilio Vicente
    Carlos Castro-Benitez
    René Adam
    Federico Tomassini
    Roberto Ivan Troisi
    Alexandros Kantas
    Karl Juergen Oldhafer
    Victoria Ardiles
    Eduardo de Santibanes
    Massimo Malago
    Pierre-Alain Clavien
    Marco Vivarelli
    Utz Settmacher
    Luca Aldrighetti
    Annals of Surgical Oncology, 2020, 27 : 1372 - 1384
  • [35] ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study
    Li, Jun
    Moustafa, Mohamed
    Linecker, Michael
    Lurje, Georg
    Capobianco, Ivan
    Baumgart, Janine
    Ratti, Francesca
    Rauchfuss, Falk
    Balci, Deniz
    Fernandes, Eduardo
    Montalti, Roberto
    Robles-Campos, Ricardo
    Bjornsson, Bergthor
    Topp, Stefan A.
    Fronek, Jiri
    Liu, Chao
    Wahba, Roger
    Bruns, Christiane
    Brunner, Stefan M.
    Schlitt, Hans J.
    Heumann, Asmus
    Stueben, Bjoern-Ole
    Izbicki, Jakob R.
    Bednarsch, Jan
    Gringeri, Enrico
    Fasolo, Elisa
    Rolinger, Jens
    Kristek, Jakub
    Hernandez-Alejandro, Roberto
    Schnitzbauer, Andreas
    Nuessler, Natascha
    Schoen, Michael R.
    Voskanyan, Sergey
    Petrou, Athanasios S.
    Hahn, Oszkar
    Soejima, Yuji
    Vicente, Emilio
    Castro-Benitez, Carlos
    Adam, Rene
    Tomassini, Federico
    Troisi, Roberto Ivan
    Kantas, Alexandros
    Oldhafer, Karl Juergen
    Ardiles, Victoria
    de Santibanes, Eduardo
    Malago, Massimo
    Clavien, Pierre-Alain
    Vivarelli, Marco
    Settmacher, Utz
    Aldrighetti, Luca
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (05) : 1372 - 1384
  • [36] Sintilimab Combined with Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma in Second-Line Setting-A Multi-Center Observational Study
    Ding, Xiaoyan
    Li, Guangxin
    Sun, Wei
    Shen, Yanjun
    Teng, Ying
    Xu, Yawen
    Li, Wendong
    Liu, Mei
    Chen, Jinglong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Multi-center Phase II Study of FLOX for Advanced Colorectal Cancer Patients in Japan: SWIFT 3 Study
    Kato, Takeshi
    Nagata, Naoki
    Fujii, Makoto
    Takemoto, Hiroshi
    Kondo, Ken
    Okuyama, Yusuke
    Tominaga, Harumi
    Sakamoto, Junichi
    Mishima, Hideyuki
    ANTICANCER RESEARCH, 2011, 31 (12) : 4657 - 4664
  • [38] A Multi-center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-arterial Temozolomide for Patients with Advanced Extremity Melanoma using Normothermic Isolated Limb Infusion
    Beasley, G.
    Speicher, P. J.
    Augustine, C.
    Jiang, B.
    Dobler, P. C.
    Peterson, B. L.
    Mosca, P. J.
    Royal, R. E.
    Ross, M. I.
    Zager, J. S.
    Tyler, D. S.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S22 - S22
  • [39] A phase I study of hepatic intra-arterial chemotherapy with gemcitabine in patients with inoperable liver metastases
    Heller, M
    Eichler, K
    Schwarz, W
    Balzer, JO
    Mack, MG
    Vogl, TJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 352S - 352S
  • [40] Phase I study of sorafenib in combination with low-dose cisplatin and fluorouracil intra-arterial infusion chemotherapy.
    Ueshima, K.
    Kudo, M.
    Tanaka, M.
    Kumada, T.
    Sakurai, T.
    Chung, H.
    Hagiwara, S.
    Minami, Y.
    Inoue, T.
    Yada, N.
    Kitai, S.
    Takita, M.
    Hayaishi, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)